Aegerion Pharma (AEGR) Announces Approval of Juxtapid in Japan as HoFH Treatment
Tweet Send to a Friend
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) announced that Japan’s Ministry of Health, Labor & Welfare (MHLW) has approved JUXTAPID for patients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE